Loredana Santo

National Hospital — India

Medicine · Health Sciences

14h-index1.1kcitations44works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Myeloma Research and Treatments(27), Bone health and treatments(9), Peptidase Inhibition and Analysis(7), Chemokine receptors and signaling(6), Chronic Lymphocytic Leukemia Research(4)

Publications44 total

Evidence of Mpox Virus Infection Among Persons Without Characteristic Lesions or Rash Presenting for First Dose of JYNNEOS Vaccine—District of Columbia, August 2022
Clinical Infectious Diseases·2023· 17 citedOpen Access
Emergency Department Visits Related to Mental Health Disorders Among Adults, by Race and Hispanic Ethnicity: United States, 2018-2020.
PubMed·2023· 16 cited
NHSR 181: Emergency Department Visits Related to Mental Health Disorders Among Adults, by Race and Hispanic Ethnicity: United States, 2018-2020
2023· 9 citedOpen Access
Abstract 834: Association between ABO and Duffy blood types and circulating chemokines and cytokines
Cancer Research·2021
Association between ABO and Duffy blood types and circulating chemokines and cytokines
Genes and Immunity·2021· 23 citedOpen Access
A Prospective Study of Circulating Chemokines and Angiogenesis Markers and Risk of Multiple Myeloma and Its Precursor
JNCI Cancer Spectrum·2019· 14 citedOpen Access
A prospective study of circulating chemokines and angiogenesis markers and risk of multiple myeloma and its precursor
Clinical Lymphoma Myeloma & Leukemia·2019
Association of Immune Marker Changes With Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma
JAMA Oncology·2019· 91 citedOpen Access
Alcohol consumption and risk of multiple myeloma in the NIH‐AARP Diet and Health Study
International Journal of Cancer·2018· 8 citedOpen Access
Abstract 4943: Circulating immunologic markers and risk of multiple myeloma and its precursor disease: A nested case-control study
Cancer Research·2018· 2 cited
Circulating resistin levels and risk of multiple myeloma in three prospective cohorts
British Journal of Cancer·2017· 17 citedOpen Access
Coxiella burnetii antibody seropositivity is not a risk factor for AIDS-related non-Hodgkin lymphoma
Blood·2017· 4 citedOpen Access
Preclinical activity of CPI-0610, a novel small-molecule bromodomain and extra-terminal protein inhibitor in the therapy of multiple myeloma
Leukemia·2016· 76 cited
Pim2 is important for regulating DNA damage response in multiple myeloma cells
Blood Cancer Journal·2016· 23 citedOpen Access
Regulation of Sclerostin Expression in Multiple Myeloma by Dkk-1: A Potential Therapeutic Strategy for Myeloma Bone Disease
Journal of Bone and Mineral Research·2016· 98 citedOpen Access
The KDM3A-KLF2-IRF4 Axis Maintains Myeloma Cell Survival
Blood·2015· 3 cited
A novel Bruton’s tyrosine kinase inhibitor CC-292 in combination with the proteasome inhibitor carfilzomib impacts the bone microenvironment in a multiple myeloma model with resultant antimyeloma activity
Leukemia·2014· 42 cited
A Novel Bruton′s Tyrosine Kinase Inhibitor CC-292 In Combination With The Proteasome Inhibitor Carfilzomib Iimpacts Multiple Myeloma Bone Microenviroment With Resultant Anti-Myeloma Activity
Blood·2013· 1 cited
Biomarkers of Bone Remodeling in Multiple Myeloma Patients to Tailor Bisphosphonate Therapy
Blood·2012· 1 cited
Role of Selective HDAC6 Inhibition On Multiple Myeloma Bone Disease
Blood·2012· 4 cited
page 1 of 3Next →

Frequent Co-authors

Noopur Raje(21), Diana Cirstea(19), Sonia Vallet(17), Teru Hideshima(15), Kenneth C. Anderson(12), Mario Boccadoro(10), Homare Eda(10), Samantha Pozzi(9), Marco Ladetto(8), Daniela Drandi(8), Güllü Görgün(6), Jonathan N. Hofmann(6), Mark P. Purdue(6), Monica Astolfi(6), Andrew J. Yee(6), Anuj Mahindra(6), Mariateresa Fulciniti(6), G Pagliano(5), Neeharika Nemani(5), Ruth M. Pfeiffer(5)